A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and tobacco use.

Fatty liver disease is becoming increasingly common, yet many people still underestimate how serious it can be. Because the condition often develops quietly and without noticeable symptoms in its ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...

Fatty liver disease is becoming increasingly common, yet many people still misunderstand what causes it and who is at risk. Because the condition often develops silently, it is easy to ignore early ...

Approval based on unprecedented Phase 3 data demonstrating statistically significant improvements in progression-free survival and overall survival versus standard of care regimens83.3% of ...